Effects of Resistance Exercise Timing on Midday Muscle Performance in Athletes

September 23, 2026 updated by: Manisa Celal Bayar University

Time-Course Effect of Post-Activation Performance Enhancement on Midday Peak Torque and Muscle Activation

This study investigated whether the timing of a resistance-based post-activation performance enhancement (PAPE) intervention performed during the morning influences muscle performance and muscle electrical activity during a standardized midday assessment in trained male athletes. Participants completed a control condition and three PAPE conditions performed at different times during the morning. The PAPE intervention consisted of back squat, kettlebell swing, and barbell hip thrust exercises. In all conditions, muscle performance was assessed between 12:00 and 12:15 using an isokinetic dynamometer, while surface electromyography (sEMG) of the rectus femoris muscle was recorded. The study compared relative peak torque and sEMG spectral power across the different PAPE timing conditions and the control condition.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

13

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Manisa, Turkey (Türkiye), 45040
        • Manisa Celal Bayar University, Faculty of Sport Sciences

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Regularly participating in systematic sport-specific training (minimum training age of 3 years)
  • Able to comply with pre-testing restrictions (avoidance of intense physical activity for 72 hours and caffeine for 2 hours prior to testing sessions)

Exclusion Criteria:

  • Any musculoskeletal, orthopedic, or health condition preventing safe participation in maximal isokinetic exercise testing
  • Current or recent injury affecting lower-limb strength or performance testing

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control (C)

Participants completed the standardized midday isokinetic performance assessment without a PAPE intervention. The assessment consisted of four maximal repetitions on an isokinetic dynamometer at 60°·s-¹ between 12:00 and 12:15, while rectus femoris surface electromyography was recorded.

Experimental: PAPE T1

Participants performed the standardized PAPE intervention between 08:00 and 09:00 before the midday performance assessment. The PAPE intervention consisted of back squat, kettlebell swing, and barbell hip thrust exercises, with one set of six repetitions at 80% of the individual estimated one-repetition maximum (e1RM) for each exercise and a 1-minute rest interval between exercises. The intervention was preceded by a 5-minute cycling warm-up at 60 rpm and 5 minutes of passive rest.

The resistance-based PAPE intervention consisted of three exercises performed in the following order: back squat, kettlebell swing, and barbell hip thrust. Participants performed one set of six repetitions at 80% of their individual estimated one-repetition maximum (e1RM) for each exercise, with a 1-minute rest interval between exercises. The intervention was preceded by a 5-minute standardized cycling warm-up at 60 rpm followed by 5 minutes of passive rest. The same PAPE protocol was performed in the T1, T2, and T3 conditions at different times before the standardized midday performance assessment.

Experimental: PAPE T2

Participants performed the standardized PAPE intervention between 10:00 and 11:00 before the midday performance assessment. The PAPE intervention consisted of back squat, kettlebell swing, and barbell hip thrust exercises, with one set of six repetitions at 80% of the individual estimated one-repetition maximum (e1RM) for each exercise and a 1-minute rest interval between exercises. The intervention was preceded by a 5-minute cycling warm-up at 60 rpm and 5 minutes of passive rest.

The resistance-based PAPE intervention consisted of three exercises performed in the following order: back squat, kettlebell swing, and barbell hip thrust. Participants performed one set of six repetitions at 80% of their individual estimated one-repetition maximum (e1RM) for each exercise, with a 1-minute rest interval between exercises. The intervention was preceded by a 5-minute standardized cycling warm-up at 60 rpm followed by 5 minutes of passive rest. The same PAPE protocol was performed in the T1, T2, and T3 conditions at different times before the standardized midday performance assessment.

Experimental: PAPE T3

Participants performed the standardized PAPE intervention between 11:45 and 12:00 before the midday performance assessment. The PAPE intervention consisted of back squat, kettlebell swing, and barbell hip thrust exercises, with one set of six repetitions at 80% of the individual estimated one-repetition maximum (e1RM) for each exercise and a 1-minute rest interval between exercises. The intervention was preceded by a 5-minute cycling warm-up at 60 rpm and 5 minutes of passive rest.

The resistance-based PAPE intervention consisted of three exercises performed in the following order: back squat, kettlebell swing, and barbell hip thrust. Participants performed one set of six repetitions at 80% of their individual estimated one-repetition maximum (e1RM) for each exercise, with a 1-minute rest interval between exercises. The intervention was preceded by a 5-minute standardized cycling warm-up at 60 rpm followed by 5 minutes of passive rest. The same PAPE protocol was performed in the T1, T2, and T3 conditions at different times before the standardized midday performance assessment.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Relative Peak Torque (RPT)
Time Frame: Measured once per condition (control, T1, T2, T3) at a fixed assessment time (12:00-12:15 PM). PAPE was performed 3.5 hours (T1), 1.5 hours (T2), or immediately (T3) before assessment. Each condition was separated by at least 48 hours.

Relative peak torque (RPT) was determined from the highest peak torque value obtained during four maximal knee extension repetitions performed on an isokinetic dynamometer at 60°·s-¹. Peak torque was normalized to body mass and expressed as N·m·kg-¹.

Measured once per condition (control, T1, T2, T3) at a fixed assessment time (12:00-12:15 PM). PAPE was performed 3.5 hours (T1), 1.5 hours (T2), or immediately (T3) before assessment. Each condition was separated by at least 48 hours.
Rectus Femoris sEMG Spectral Power
Time Frame: Measured once per condition (control, T1, T2, T3) at a fixed assessment time (12:00-12:15 PM). PAPE was performed 3.5 hours (T1), 1.5 hours (T2), or immediately (T3) before assessment. Each condition was separated by at least 48 hours.

Surface electromyography (sEMG) of the rectus femoris muscle was recorded during the maximal isokinetic knee extension repetitions. Spectral power was calculated from the processed sEMG signal using fast Fourier transform (FFT) analysis and expressed as µV²/Hz.

Measured once per condition (control, T1, T2, T3) at a fixed assessment time (12:00-12:15 PM). PAPE was performed 3.5 hours (T1), 1.5 hours (T2), or immediately (T3) before assessment. Each condition was separated by at least 48 hours.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 3, 2025

Primary Completion (Actual)

August 20, 2025

Study Completion (Actual)

September 15, 2025

Study Registration Dates

First Submitted

September 15, 2026

First Submitted That Met QC Criteria

September 23, 2026

First Posted (Actual)

September 25, 2026

Study Record Updates

Last Update Posted (Actual)

September 25, 2026

Last Update Submitted That Met QC Criteria

September 23, 2026

Last Verified

September 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • MCBU_PAPE_2025

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data are not planned to be publicly shared due to participant confidentiality and data protection considerations.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.